$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

$sem Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000162828018002017 Filed on February 22, 2018

Income Statement

Concept	2017 Q4	2017	2016 Q4
Revenue	$1.114B	$4.444B	$1.046B
YoY Change	6.51%	3.68%	0.68%
Cost Of Revenue	$946.9M	$3.734B	$909.9M
YoY Change	4.07%	1.89%	0.84%
Gross Profit	$147.4M	$709.4M	$136.4M
YoY Change	8.06%	14.21%	-0.37%
Gross Profit Margin	13.23%	15.97%	13.04%
Selling, General & Admin	$30.60M	$114.0M	$43.20M
YoY Change	-29.17%	6.64%	7.2%
% of Gross Profit	20.76%	16.07%	31.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$40.40M	$142.6M	$37.40M
YoY Change	8.02%	10.54%	9.04%
% of Gross Profit	27.41%	20.1%	27.42%
Operating Expenses	$71.00M	$274.0M	$80.70M
YoY Change	-12.02%	8.64%	8.18%
Operating Profit	$76.35M	$355.9M	$55.75M
YoY Change	36.97%	18.69%	-10.52%
Interest Expense	-$33.10M	$154.7M	-$36.90M
YoY Change	-10.3%	-9.04%	26.8%
% of Operating Profit	-43.35%	43.47%	-66.19%
Other Income/Expense, Net
YoY Change
Pretax Income	$43.30M	$202.5M	$24.40M
YoY Change	77.46%	12.02%	-26.51%
Income Tax	-$6.300M	-$18.18M	$3.900M
% Of Pretax Income	-14.55%	-8.98%	15.98%
Net Earnings	$100.8M	$177.2M	$20.17M
YoY Change	399.69%	53.52%	-31.15%
Net Earnings / Revenue	9.04%	3.99%	1.93%
Basic Earnings Per Share	$0.75	$1.33	$0.15
Diluted Earnings Per Share	$0.75	$1.33	$0.15
COMMON SHARES
Basic Shares Outstanding		129.0M shares
Diluted Shares Outstanding		129.1M shares

Balance Sheet

Concept	2017 Q4	2017	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.5M	$122.5M	$99.00M
YoY Change	23.74%	23.74%	587.5%
Cash & Equivalents	$122.5M	$122.5M	$99.03M
Short-Term Investments
Other Short-Term Assets	$75.16M	$106.6M	$77.70M
YoY Change	-3.27%	18.31%	-40.78%
Inventory
Prepaid Expenses
Receivables	$691.7M	$691.7M	$573.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$920.8M	$920.8M	$762.9M
YoY Change	20.7%	20.7%	1.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$912.6M	$912.6M	$892.2M
YoY Change	2.28%	2.29%	3.25%
Goodwill	$2.783B		$2.751B
YoY Change	1.16%		18.85%
Intangibles	$326.5M		$340.6M
YoY Change	-4.12%
Long-Term Investments
YoY Change
Other Assets	$184.4M	$184.4M	$173.9M
YoY Change	6.02%	6.04%	22.41%
Total Long-Term Assets	$4.206B	$4.206B	$4.158B
YoY Change	1.17%	1.17%	14.24%
TOTAL ASSETS
Total Short-Term Assets	$920.8M	$920.8M	$762.9M
Total Long-Term Assets	$4.206B	$4.206B	$4.158B
Total Assets	$5.127B	$5.127B	$4.921B
YoY Change	4.2%	4.2%	12.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$128.2M	$128.2M	$126.6M
YoY Change	1.29%	1.26%	-7.89%
Accrued Expenses	$416.5M	$416.5M	$392.1M
YoY Change	6.22%	6.22%	15.97%
Deferred Revenue
YoY Change
Short-Term Debt	$29.50M	$29.50M	$39.40M
YoY Change	-25.13%	-25.13%	37.76%
Long-Term Debt Due	$22.20M	$22.20M	$13.70M
YoY Change	62.04%	62.04%	-93.92%
Total Short-Term Liabilities	$605.4M	$605.4M	$571.6M
YoY Change	5.91%	5.91%	-21.62%
LONG-TERM LIABILITIES
Long-Term Debt	$2.678B	$2.678B	$2.685B
YoY Change	-0.28%	-0.28%	24.28%
Other Long-Term Liabilities	$145.7M	$145.7M	$136.5M
YoY Change	6.73%	6.74%	2.49%
Total Long-Term Liabilities	$145.7M	$2.823B	$136.5M
YoY Change	6.73%	0.06%	-94.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$605.4M	$605.4M	$571.6M
Total Long-Term Liabilities	$145.7M	$2.823B	$136.5M
Total Liabilities	$3.554B	$4.304B	$3.593B
YoY Change	-1.08%	4.85%	1.79%
SHAREHOLDERS EQUITY
Retained Earnings	$359.7M		$371.7M
YoY Change	-3.22%
Common Stock	$463.6M		$444.0M
YoY Change	4.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$823.4M	$823.4M	$815.7M
YoY Change
Total Liabilities & Shareholders Equity	$5.127B	$5.127B	$4.921B
YoY Change	4.2%	4.2%	12.12%

Cashflow Statement

Concept	2017 Q4	2017	2016 Q4
OPERATING ACTIVITIES
Net Income	$100.8M	$177.2M	$20.17M
YoY Change	399.69%	53.52%	-31.15%
Depreciation, Depletion And Amortization	$40.40M	$142.6M	$37.40M
YoY Change	8.02%	10.54%	9.04%
Cash From Operating Activities	$108.1M	$238.1M	$65.80M
YoY Change	64.29%	-31.3%	1216.0%
INVESTING ACTIVITIES
Capital Expenditures	-$59.40M	-$233.2M	-$43.30M
YoY Change	37.18%	44.31%	-36.88%
Acquisitions		$27.39M
YoY Change		-94.2%
Other Investing Activities	$36.50M	$40.30M	-$48.00M
YoY Change	-176.04%	-110.26%	293.44%
Cash From Investing Activities	-$23.00M	-$193.0M	-$91.30M
YoY Change	-74.81%	-65.19%	12.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-69.90M	-$21.65M	56.30M
YoY Change	-224.16%	-107.41%	-16.72%
NET CHANGE
Cash From Operating Activities	108.1M	$238.1M	65.80M
Cash From Investing Activities	-23.00M	-$193.0M	-91.30M
Cash From Financing Activities	-69.90M	-$21.65M	56.30M
Net Change In Cash	15.20M	$23.52M	30.80M
YoY Change	-50.65%	-72.2%	-471.08%
FREE CASH FLOW
Cash From Operating Activities	$108.1M	$238.1M	$65.80M
Capital Expenditures	-$59.40M	-$233.2M	-$43.30M
Free Cash Flow	$167.5M	$471.3M	$109.1M
YoY Change	53.53%	-7.26%	48.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001320414
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	134103978	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	1636498421	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	SELECT MEDICAL HOLDINGS CORP
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015	sem	Adjusted Ebitda AdjustedEbitda	399165000	USD
CY2016	sem	Adjusted Ebitda AdjustedEbitda	465807000	USD
CY2017	sem	Adjusted Ebitda AdjustedEbitda	537992000	USD
CY2015	sem	Contractual Dividends ContractualDividends	0	USD
CY2016	sem	Contractual Dividends ContractualDividends	0	USD
CY2017	sem	Contractual Dividends ContractualDividends	0	USD
CY2016	sem	Deductibles Co Paymentsand Self Insured Amountsas Percentageof Accounts Receivable DeductiblesCoPaymentsandSelfInsuredAmountsasPercentageofAccountsReceivable	0.012
CY2017	sem	Deductibles Co Paymentsand Self Insured Amountsas Percentageof Accounts Receivable DeductiblesCoPaymentsandSelfInsuredAmountsasPercentageofAccountsReceivable	0.006
CY2016Q4	sem	Deferred Tax Assets Tax Benefit On Uncertain Tax Positions DeferredTaxAssetsTaxBenefitOnUncertainTaxPositions	499000	USD
CY2017Q4	sem	Deferred Tax Assets Tax Benefit On Uncertain Tax Positions DeferredTaxAssetsTaxBenefitOnUncertainTaxPositions	503000	USD
CY2017	sem	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2015	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate Federal Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateFederalPercent	0.000
CY2016	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate Federal Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateFederalPercent	0.000
CY2017	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate Federal Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateFederalPercent	-0.375
CY2015	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0.000
CY2016	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	0.000
CY2017	sem	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rate State Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateStatePercent	-0.028
CY2017Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear1	17547000	USD
CY2017Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year2 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear2	11946000	USD
CY2017Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year3 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear3	6315000	USD
CY2017Q4	sem	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year4 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear4	1472000	USD
CY2017Q4	sem	Employee Service Share Based Compensation Nonvested Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Recognizedin Year5 EmployeeServiceShareBasedCompensationNonvestedEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedRecognizedinYear5	6000	USD
CY2015	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	250170000	USD
CY2016	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	274952000	USD
CY2017	sem	Equity Method Investment Summarized Financial Information Operating Expenses EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses	289224000	USD
CY2015	sem	Gain Loss On Disposition Of Assets And Business GainLossOnDispositionOfAssetsAndBusiness	1098000	USD
CY2016	sem	Gain Loss On Disposition Of Assets And Business GainLossOnDispositionOfAssetsAndBusiness	46488000	USD
CY2017	sem	Gain Loss On Disposition Of Assets And Business GainLossOnDispositionOfAssetsAndBusiness	10349000	USD
CY2017	sem	Income Tax Period Of Review For Assessment Of Deferred Tax Assets IncomeTaxPeriodOfReviewForAssessmentOfDeferredTaxAssets	P3Y
CY2016	sem	Non Operating Gain Related To Final Settlement Of Sale Of Entity NonOperatingGainRelatedToFinalSettlementOfSaleOfEntity	2500000	USD
CY2015	sem	Non Operating Income Loss From Equity Method Investments NonOperatingIncomeLossFromEquityMethodInvestments	29600000	USD
CY2016	sem	Non Operating Income Loss From Equity Method Investments NonOperatingIncomeLossFromEquityMethodInvestments	-5100000	USD
CY2017	sem	Number Of Department Of Veterans Affairs NumberOfDepartmentOfVeteransAffairs	32	hospital
CY2017	sem	Number Of Occupational Health Centers NumberOfOccupationalHealthCenters	312	hospital
CY2017	sem	Number Of Onsite Facilities NumberOfOnsiteFacilities	105	hospital
CY2017	sem	Number Of Outpatient Clinics Operated By Entity NumberOfOutpatientClinicsOperatedByEntity	1616	hospital
CY2015	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	165300000	USD
CY2016	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	220800000	USD
CY2017	sem	Operating Leases Facility Rent Expense Unrelated Parties OperatingLeasesFacilityRentExpenseUnrelatedParties	224200000	USD
CY2016Q4	sem	Outstanding Book Overdrafts OutstandingBookOverdrafts	39362000	USD
CY2017Q4	sem	Outstanding Book Overdrafts OutstandingBookOverdrafts	29463000	USD
CY2015	sem	Proceeds From Sale Of Assets And Divestiture Of Businesses ProceedsFromSaleOfAssetsAndDivestitureOfBusinesses	1767000	USD
CY2016	sem	Proceeds From Sale Of Assets And Divestiture Of Businesses ProceedsFromSaleOfAssetsAndDivestitureOfBusinesses	80463000	USD
CY2017	sem	Proceeds From Sale Of Assets And Divestiture Of Businesses ProceedsFromSaleOfAssetsAndDivestitureOfBusinesses	80350000	USD
CY2017	sem	Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit	-71500000	USD
CY2015	sem	Temporary Equity Acquisition Of Non Controlling Interests TemporaryEquityAcquisitionOfNonControllingInterests	14196000	USD
CY2015	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	2909000	USD
CY2016	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	3231000	USD
CY2017	sem	Temporary Equity Distributions To Non Controlling Interests TemporaryEquityDistributionsToNonControllingInterests	5207000	USD
CY2015	sem	Temporary Equity Issuance Of Non Controlling Interests TemporaryEquityIssuanceOfNonControllingInterests	218005000	USD
CY2015	sem	Temporary Equity Repurchase Of Redeemable Non Controlling Interests TemporaryEquityRepurchaseOfRedeemableNonControllingInterests	876000	USD
CY2016	sem	Temporary Equity Repurchase Of Redeemable Non Controlling Interests TemporaryEquityRepurchaseOfRedeemableNonControllingInterests	2753000	USD
CY2017	sem	Temporary Equity Repurchase Of Redeemable Non Controlling Interests TemporaryEquityRepurchaseOfRedeemableNonControllingInterests	127000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Expired State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseExpiredStateNetOperatingLossesAmount	-200000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Federal Net Operating Losses Acquired In Business Combination Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseFederalNetOperatingLossesAcquiredInBusinessCombinationAmount	-14100000	USD
CY2017	sem	Valuation Allowance Deferred Tax Asset Increase Decrease Newly Generated State Net Operating Losses Amount ValuationAllowanceDeferredTaxAssetIncreaseDecreaseNewlyGeneratedStateNetOperatingLossesAmount	900000	USD
CY2015	sem	Write Off Of Deferred Debt Issuance Cost And Discounts WriteOffOfDeferredDebtIssuanceCostAndDiscounts	0	USD
CY2016	sem	Write Off Of Deferred Debt Issuance Cost And Discounts WriteOffOfDeferredDebtIssuanceCostAndDiscounts	11626000	USD
CY2017	sem	Write Off Of Deferred Debt Issuance Cost And Discounts WriteOffOfDeferredDebtIssuanceCostAndDiscounts	6527000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	126558000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128194000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	573752000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	691732000	USD
CY2016Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	83261000	USD
CY2017Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	92875000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	512751000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	630664000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	443908000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	463499000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	53000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1846000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14679000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17413000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19284000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	63787000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75544000	USD
CY2015	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	9543000	USD
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	15656000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11130000	USD
CY2015Q4	us-gaap	Assets Assets	4388678000	USD
CY2016Q4	us-gaap	Assets Assets	4920626000	USD
CY2017Q4	us-gaap	Assets Assets	5127166000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	762903000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	920826000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	36744000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	32861000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30043000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3354000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14435000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99029000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122549000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11081000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	84594000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23520000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.10
CY2016	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2017	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132596758	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134114715	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	132596758	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	134114715	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	132000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	134000	USD
CY2015	us-gaap	Cost Of Services CostOfServices	3211541000	USD
CY2016	us-gaap	Cost Of Services CostOfServices	3664843000	USD
CY2017	us-gaap	Cost Of Services CostOfServices	3734176000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	3467946000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	3986174000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	4087725000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	63626000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	54726000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	45809000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	74494000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	68055000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	54140000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	10868000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	13329000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8331000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2747856000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2744080000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2752974000	USD
CY2017Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2761735000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	13734000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	13924000	USD
CY2016Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	21396000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	19391000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2058000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12591000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-72324000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	307280000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	211321000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	199078000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124917000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	746000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	319000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	1567000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	1452000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	156019000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	118781000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	129598000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	105795000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	39481000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	36112000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3496000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3040000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	70199000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	50936000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9533000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6591000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	10735000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8792000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	19763000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Self Insurance DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance	11036000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26421000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12986000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	177700000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	177682000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	105500000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	105526000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	0	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	4528000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	3885000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	4457000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5413000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	3673000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	271914000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	179055000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	26068000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	19608000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	14700000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	15200000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2015	us-gaap	Depreciation Depreciation	96100000	USD
CY2016	us-gaap	Depreciation Depreciation	129000000	USD
CY2017	us-gaap	Depreciation Depreciation	142600000	USD
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	104981000	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	145311000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	160011000	USD
CY2016	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	35600000	USD
CY2015	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	13129000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.88
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.348
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.307
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.090
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.009
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.002
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.073
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	-0.067
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.020
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.005
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.014
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.014
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.017
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.007
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.013
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.004
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.037
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.023
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.013
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.006
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	146397000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	160562000	USD
CY2015	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	13969000	USD
CY2016	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20476000	USD
CY2017	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	20006000	USD
CY2015	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2016	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	5339000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	31986000	USD
CY2016	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	4825000	USD
CY2017	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-174000	USD
CY2017	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	169569000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	182272000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	90656000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Assets EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets	102908000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	32520000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	37113000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	122665000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	131408000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	169569000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	182272000	USD
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	37951000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	43410000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	45648000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	78913000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Assets EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets	79364000	USD
CY2016Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	14384000	USD
CY2017Q4	us-gaap	Equity Method Investment Summarized Financial Information Noncurrent Liabilities EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities	13751000	USD
CY2015	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	289994000	USD
CY2016	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	320078000	USD
CY2017	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	336349000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1846000	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2017	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27339000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46500000	USD
CY2015	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	29647000	USD
CY2016	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	2779000	USD
CY2017	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-11626000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19719000	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	92052000	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	106927000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	114047000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	2314624000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	2751000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	2782812000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	446702000	USD
CY2017	us-gaap	Goodwill Transfers GoodwillTransfers	0	USD
CY2016	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	15151000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	208432000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	180734000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	202461000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16811000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19943000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	21054000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72436000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55464000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18184000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	79420000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	70756000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	64991000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2345000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15492000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3903000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	92572000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39320000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	197191000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7200000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	46292000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	17341000	USD
CY2015	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	6869000	USD
CY2016	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	10746000	USD
CY2017	us-gaap	Increase Decrease In Book Overdrafts IncreaseDecreaseInBookOverdrafts	-9899000	USD
CY2015	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2503000	USD
CY2016	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-17450000	USD
CY2017	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1597000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4713000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-9290000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	886000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	274000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	155000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	171000	shares
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	367901000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	373019000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	340562000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	326519000	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-112816000	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-170081000	USD
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-154703000	USD
CY2015	us-gaap	Interest Paid InterestPaid	103166000	USD
CY2016	us-gaap	Interest Paid InterestPaid	142640000	USD
CY2017	us-gaap	Interest Paid InterestPaid	149156000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	22325000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19885000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	3592566000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	3553744000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4920626000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5127166000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	571635000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	605403000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	2698989000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	2699902000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2685333000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2677715000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	13656000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	22187000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1089274000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	22186000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	851332000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	728426000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	37987000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	14875000	USD
CY2016Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2017Q4	us-gaap	Loss Contingency Accrual Insurance Related Assessment Discount Rate LossContingencyAccrualInsuranceRelatedAssessmentDiscountRate	0.03
CY2016Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	147400000	USD
CY2017Q4	us-gaap	Loss Contingency Discounted Amount Of Insurance Related Assessment Liability LossContingencyDiscountedAmountOfInsuranceRelatedAssessmentLiability	157100000	USD
CY2016	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	152700000	USD
CY2017	us-gaap	Loss Contingency Undiscounted Amount Of Insurance Related Assessment Liability LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability	162100000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	90176000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	109236000	USD
CY2015	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-1010000	USD
CY2016	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-177216000	USD
CY2017	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-187506000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9732000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7324000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	5293000	USD
CY2015	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	219000	USD
CY2016	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-654000	USD
CY2017	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-7000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1014420000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	292311000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21646000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1211754000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-554320000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-192965000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	208415000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	346603000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238131000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	130736000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	20172000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	115411000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	54833000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	33935000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	6471000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	15870000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	42055000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	18462000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	100797000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	177184000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5260000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9859000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43461000	USD
CY2015	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	7450000	USD
CY2016	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-2620000	USD
CY2017	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	7822000	USD
CY2015	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-2190000	USD
CY2016	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	12479000	USD
CY2017	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	35639000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	126906000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	111890000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	171426000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2888000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2514000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	14569000	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	50178000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	18280000	USD
CY2015	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	29647000	USD
CY2016	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	42651000	USD
CY2017	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-49000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	business_segment
CY2017Q4	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	business_segment
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	business_segment
CY2017Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	47	hospital
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	274790000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	86886000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	101054000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	56162000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	55745000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	299847000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	91765000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	115663000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	72098000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	76352000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	355878000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1209845000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	224359000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	91351000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	121881000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	156494000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	191120000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	424640000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	214900000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	265100000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	267400000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	140076000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	143166000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	77699000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	75158000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	173944000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184418000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	136520000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	145709000	USD
CY2015	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	15827000	USD
CY2016	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	2929000	USD
CY2017	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	4753000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4392000	USD
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13129000	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	12637000	USD
CY2016	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	10555000	USD
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	10500000	USD
CY2015	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	1095000	USD
CY2016	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	2099000	USD
CY2017	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	120000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1061628000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	472206000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	27390000	USD
CY2015	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2347000	USD
CY2016	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4723000	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12682000	USD
CY2015	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	182642000	USD
CY2016	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	161633000	USD
CY2017	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	233243000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	12423000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	31387000	USD
CY2015	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	623575000	USD
CY2016	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	795344000	USD
CY2017	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	1139487000	USD
CY2015	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1135000000	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	575000000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	970000000	USD
CY2015	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	13374000	USD
CY2016	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	27721000	USD
CY2017	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	46621000	USD
CY2015	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	217065000	USD
CY2016	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	11846000	USD
CY2017	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	9982000	USD
CY2015	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	33096000	USD
CY2016	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	3779000	USD
CY2017	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1649000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1672000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2017000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	135996000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	125270000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	220645000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1404968000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1543255000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	892217000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	912591000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	59372000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	69093000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	79491000	USD
CY2014Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	10985000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	238221000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	422159000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	640818000	USD
CY2015	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	18136000	USD
CY2016	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	21401000	USD
CY2017	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	20647000	USD
CY2015	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	895000000	USD
CY2016	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	655000000	USD
CY2017	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	960000000	USD
CY2015	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	29134000	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	438034000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1179442000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	371685000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	359735000	USD
CY2015	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	146000000	USD
CY2016	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	164200000	USD
CY2017	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	178100000	USD
CY2016Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1097631000	USD
CY2016Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1053795000	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3742736000	USD
CY2016Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1088330000	USD
CY2016Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1046265000	USD
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4286021000	USD
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1111361000	USD
CY2017Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1120675000	USD
CY2017Q3	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1097166000	USD
CY2017Q4	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1114401000	USD
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4443603000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	14985000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	17413000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	19284000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	529720	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	291775	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.09
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.26
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	800000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	11100	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2400000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	529720	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	291775	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.09
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.26
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.89
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.51
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2400000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M18D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M18D
CY2015	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	183000	shares
CY2016	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	232000	shares
CY2017	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	280000	shares
CY2015	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1385000	shares
CY2016	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1426000	shares
CY2017	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1598000	shares
CY2015	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	304000	shares
CY2016	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	82000	shares
CY2017	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	27000	shares
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	183000	shares
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	202000	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	226845	shares
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	227000	shares
CY2015	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	13916000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	16640000	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	18291000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1649000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1672000	USD
CY2015	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1032334	shares
CY2016	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2017	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	0	shares
CY2015	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	15827000	USD
CY2016	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2929000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2017000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	775240000	USD
CY2017	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4753000	USD
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000.0	USD
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	185200000	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13600000	USD
CY2016	us-gaap	Stockholders Equity Other StockholdersEquityOther	-400000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	908517000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	905901000	USD
CY2017	us-gaap	Stockholders Equity Other StockholdersEquityOther	-654000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	815725000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	823368000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	932604000	USD
CY2015	us-gaap	Stockholders Equity Other StockholdersEquityOther	-87000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	9071000	USD
CY2015	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	1010000	USD
CY2016	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	177216000	USD
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	187506000	USD
CY2015	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-2190000	USD
CY2016	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	12479000	USD
CY2017	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	35639000	USD
CY2016	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	227000	USD
CY2017	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	848000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	35133000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	30254000	USD
CY2015	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3830000	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3521000	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5758000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3800000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2800000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-13400000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127752000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127968000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	129126000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127478000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127813000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128955000	shares
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash balances and trade receivables. The Company invests its excess cash with large financial institutions. The Company grants unsecured credit to its patients, most of who reside in the service area of the Company’s facilities and are insured under third-party payor agreements. Because of the geographic diversity of the Company’s facilities and non-governmental third-party payors, Medicare represents the Company’s only significant concentration of credit risk.</font></div></div>
CY2017	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts in order to conform to current year presentation. As discussed above, the condensed consolidated balance sheet at December 31, 2016 has been changed in order to conform to the current year balance sheet presentation for the adoption of ASU 2015-17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Classification of Deferred Taxes.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingencies, at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but not limited to: accounts receivable and allowance for doubtful accounts, depreciable lives of assets, intangible assets, insurance, and income taxes. Future events and their effects cannot be predicted with certainty; accordingly, the Company’s accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. The Company’s management evaluates and updates assumptions and estimates on an ongoing basis. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-18-002017-index-headers.html	Edgar Link	pending
0001628280-18-002017-index.html	Edgar Link	pending
0001628280-18-002017.txt	Edgar Link	pending
0001628280-18-002017-xbrl.zip	Edgar Link	pending
chart-ed4dc0e5d79ec3daaa5a02.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sem-12311710k.htm	Edgar Link	pending
sem-12311710kex12.htm	Edgar Link	pending
sem-12311710kex211.htm	Edgar Link	pending
sem-12311710kex23.htm	Edgar Link	pending
sem-12311710kex311.htm	Edgar Link	pending
sem-12311710kex312.htm	Edgar Link	pending
sem-12311710kex321.htm	Edgar Link	pending
sem-20171231.xml	Edgar Link	completed
sem-20171231.xsd	Edgar Link	pending
sem-20171231_cal.xml	Edgar Link	unprocessable
sem-20171231_def.xml	Edgar Link	unprocessable
sem-20171231_lab.xml	Edgar Link	unprocessable
sem-20171231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem

2017 Q4 Form 10-K Financial Statement

#000162828018002017 Filed on February 22, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM SELECT MEDICAL HOLDINGS CORP Stock $sem

2017 Q4 Form 10-K Financial Statement

#000162828018002017 Filed on February 22, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEM
SELECT MEDICAL HOLDINGS CORP Stock $sem